(600062)"China Resources Double-Crane Pharmaceutical Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 600062 · · 13 pages · Chinese
China Resources Double-Crane Pharmaceutical Co., Ltd. on 6ix
Earlier from China Resources Double-Crane Pharmaceutical
- (600062)"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
- (600062)"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtaining the Drug Registration Certificate for Baricitinib Tablets by the Wholly-owned Subsidiary Beijing Wanhui Double-Crane Pharmaceutical Co., Ltd.
- (600062)"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtaining the Drug Registration Certificate for Composite Potassium Hydrogen Phosphate Injection by the Wholly-owned Subsidiary Anhui Double-Crane Pharmaceutical Co., Ltd.
- (600062)"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Mycophenolate Mofetil for Injection of the Wholly-owned Subsidiary Double-Crane Pharmaceutical (Hainan) Co., Ltd. Passing the Consistency Evaluation of Quality and Efficacy for Generic Drugs
- (600062)"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtaining U.S. FDA Clinical Trial Approval for DC7001A Capsules by Wholly-owned Subsidiary Beijing Double-Crane Runchuang Technology Co., Ltd.
Later from China Resources Double-Crane Pharmaceutical
- (600062)"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Passing the Drug GMP Compliance Inspection by the Controlled Subsidiary Henan Zhongshuai Pharmaceutical Sci & Tech Co., Ltd.
- (600062)"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Receipt of the Approval Notice for the Supplementary Drug Application for Perindopril Amlodipine Tablets (Ⅲ) by the Controlled Subsidiary Shuanghe Tian'an Pharmaceutical (Guizhou) Co., Ltd.
- (600062)"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtaining Drug Registration Certificate by the Company and Its Subsidiaries for Certain Drugs
Follow China Resources Double-Crane Pharmaceutical into a list and get an email when it puts out news.
Follow China Resources Double-Crane Pharmaceutical